A detailed history of Efg Asset Management (North America) Corp. transactions in Zoetis Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 19,513 shares of ZTS stock, worth $3.22 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
19,513
Previous 26,434 26.18%
Holding current value
$3.22 Million
Previous $4.58 Million 16.8%
% of portfolio
0.65%
Previous 0.81%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$172.58 - $196.48 $1.19 Million - $1.36 Million
-6,921 Reduced 26.18%
19,513 $3.81 Million
Q2 2024

Jul 25, 2024

BUY
$145.54 - $178.83 $213,943 - $262,880
1,470 Added 5.89%
26,434 $4.58 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $787,263 - $950,114
4,752 Added 23.51%
24,964 $4.22 Million
Q4 2023

Feb 08, 2024

SELL
$151.44 - $200.09 $385,717 - $509,629
-2,547 Reduced 11.19%
20,212 $3.99 Million
Q3 2023

Nov 02, 2023

SELL
$167.14 - $192.77 $578,304 - $666,984
-3,460 Reduced 13.2%
22,759 $3.96 Million
Q2 2023

Jul 28, 2023

SELL
$160.94 - $186.23 $459,483 - $531,686
-2,855 Reduced 9.82%
26,219 $4.52 Million
Q1 2023

Apr 27, 2023

SELL
$145.48 - $175.02 $20,803 - $25,027
-143 Reduced 0.49%
29,074 $4.84 Million
Q4 2022

Feb 03, 2023

BUY
$131.14 - $157.47 $197,890 - $237,622
1,509 Added 5.45%
29,217 $4.28 Million
Q3 2022

Oct 28, 2022

SELL
$148.29 - $182.55 $355,302 - $437,389
-2,396 Reduced 7.96%
27,708 $4.11 Million
Q2 2022

Aug 04, 2022

SELL
$155.97 - $200.09 $435,312 - $558,451
-2,791 Reduced 8.48%
30,104 $5.18 Million
Q1 2022

Apr 26, 2022

SELL
$181.39 - $234.03 $1.16 Million - $1.5 Million
-6,397 Reduced 16.28%
32,895 $6.21 Million
Q4 2021

Feb 18, 2022

BUY
$193.69 - $247.03 $7.61 Million - $9.71 Million
39,292 New
39,292 $9.59 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.